For more than 30 years, Haemonetics has been a global leader in blood processing technology. The Company has two families of products:

Donor Products - These products are marketed to the blood donation industry and include products that automate the blood donation process and the processing of blood.

Patient Products - These products are marketed to the surgical suite for blood loss management for patients. The products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.

Through its history, Haemonetics has earned a solid reputation for product innovation, technical expertise, and operational excellence. Today, Haemonetics' products, internal R&D, marketing partnerships, and product acquisitions reflect the Company's unwavering commitment to provide safe and available blood for patient transfusions and for use in pharmaceuticals.

Haemonetics is publicly traded on the New York Stock Exchange under the ticker HAE. The company employs more than 1,600 people in offices located in 16 countries. It markets its products in over 50 countries and derives revenues almost equally from Asia, Europe, and the Americas.